Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Clinical Trials, Diabetes, Drugs (Pharmaceuticals), Eli Lilly and Company, GLP-1 RAs (Drug), orforglipron, Ozempic (Drug), Research, United States
←Gloria Gaynor Hit Hard Times After ‘I Will Survive.’ Now She’s Back.
Nvidia C.E.O. Meets With Chinese Trade Officials in Beijing→

More posts

  • From Practical Gifts to Wellness Moments: Holiday Trends to Watch for 2026

  • The Scoop with Moynat’s Aydha Mehnaz: On Launching Her New Consultancy Venture Avari

  • Wig Business Is Big Business

  • Is Merch Stealing Luxury’s Aspirational Consumer?

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube